Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer.

[This corrects the article DOI: 10.1186/s40425-017-0240-7.].

Erratum

After publication of this article [1], it was noticed that Table 3 contained errors introduced during the production process. The corrected Table 3 can be seen below and the original article has been updated to correct the errors.

Table 3

Multivariate Cox proportional hazard analysis for DFS and OS of patients with non-mesastatic invasive breast cancer

	DFS			OS
	Hazard Ratio	P	95.0% CI for HR (range)	Hazard Ratio	P	95.0% CI for HR (range)
TNM stageb	2.180	0.009	1.219–3.898	3.937	0.006	1.494–10.371
Signaturesb	1.560	0.138	0.866–2.810	2.085	0.091	0.889–4.890
Model before stepwise selection
Agea	1.031	0.948	0.411–2.589	4.391	0.188	0.486–39.703
T statusb	2.613	0.010	1.255–5.439	3.679	0.028	1.148–11.793
N stageb	1.222	0.512	0.671–2.225	1.125	0.815	0.420–3.010
Gradeb	1.142	0.750	0.504–2.585	4.189	0.027	1.180–14.867
HER-2/neu	0.928	0.884	0.342–2.520	0.066	0.016	0.007–0.066
Hormone Receptors	0.277	0.004	0.277–0.669	0.618	0.007	0.046–0.621
Signaturesb	2.063	0.041	1.031–4.126	4.850	0.014	1.374–17.122
Model after stepwise selection
T statusb	2.999	0.001	1.602–5.615	3.522	0.005	1.477–8.398
Hormone Receptors	0.269	0.002	0.116–0.621	0.231	0.014	0.072–0.742
Signaturesb	2.146	0.027	1.091–4.219	4.273	0.006	1.521–11.999

aAge under 50 and over 50 years old

bAll categorical covariates were transformed into numeric codes as follows: T status (T1; 1, T2; 2, T3; 3), N stage (NO; 0, N1; 1, N2; 2, N3; 3), Grade (G1; 1, G2; 2, G3; 3), Signatures (FCIS; 1, Rest; 2, UCIS; 3) TNM stage (I; 1, II; 2, III; 3)